We verified that in the absence of any transfection reagents in vitro, TLR9-positive PC3-luc and DU145 prostate cancer cells, efficiently internalize CpG-siRNA (Figure 4A and Supplementary Figure S7A). This evidence concerns the gene TLR9 and prostate carcinoma.